Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological Study
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01020682
Recruitment Status : Unknown
Verified November 2009 by University Hospital, Grenoble. Recruitment status was: Recruiting
First Posted : November 25, 2009
Last Update Posted : November 25, 2009
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France
Apathy has been reported to occur after subthalamic nucleus stimulation (STN-DBS), a treatment of motor complications in advanced Parkinson's disease (PD). It is not known whether postoperative apathy is related to dopamine withdrawal or a side effect of STN DBS. The researchers investigated potential predictors of apathy, and the effect of dopamine agonist treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.